Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Walt
AddedFeb 15, 2024
UpdatedJun 28, 2026
David Walt

David Walt

Co-Founder, Illumina

CrunchbaseLinkedInThe Org

David Walt's Career

Illumina
Illumina

San Diego, CA, US

Co-Founder
Quanterix
Quanterix

Billerica, MA, US

Board Member· Board
Protillion Biosciences
Protillion Biosciences

Burlingame, CA, US

Co-Founder
Ultivue
Ultivue

Cambridge, MA, US

Co-Founder
LISNR
LISNR

Cincinnati, OH, US

Board Member· Board
SoLo Funds
SoLo Funds

Los Angeles, CA, US

Co-Founder
Sherlock Biosciences
Sherlock Biosciences

Allston-Brighton, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Walt's Career

Illumina
Illumina
Public$778M11.5k1998San Diego, CA, US
Co-Founder

Leadership at Illumina

John ThompsonJohn ThompsonBoard Member
Gary GuthartGary GuthartBoard Member
Jacob ThaysenJacob ThaysenBoard Member
Philip SchillerPhilip SchillerBoard Member
Larry BockLarry BockCo-Founder
Jay FlatleyJay FlatleyBoard Member

Similar to Illumina

10x Genomics10x GenomicsPleasanton, CA, USGene Sequencingest. 201210x GenomicsPleasanton, CA, US · est. 2012

10x Genomics: A leading American biotech firm, innovating in gene sequencing since 2012.

Public · $242.6M448
Element BiosciencesElement BiosciencesSan Diego, CA, USGenetic Analysis Toolsest. 2017Element BiosciencesSan Diego, CA, US · est. 2017

San Diego-based biotech firm specializing in the development of genetic analysis tools.

Series C · $401M348
Bionano GenomicsBionano GenomicsSan Diego, CA, USGenome Mapping, Softwareest. 2003Bionano GenomicsSan Diego, CA, US · est. 2003

Bionano Genomics, based in San Diego, offers advanced genome mapping and structural variation detection.

Public · $288.1M405
Quanterix
Quanterix
Public$533.3M1252007Billerica, MA, US
Board Member· Board

Leadership at Quanterix

Nick NaclerioNick NaclerioBoard Member
Sarah HlavinkaSarah HlavinkaBoard Member
Masoud ToloueMasoud ToloueCEO
Kevin HrusovskyKevin HrusovskyBoard Member
Martin MadausMartin MadausBoard Member
Protillion Biosciences
Protillion Biosciences
Series A$18M92019Burlingame, CA, US
Co-Founder

Leadership at Protillion Biosciences

William GreenleafWilliam GreenleafCo-Founder
Curtis LaytonCurtis LaytonCo-Founder & CEO
Ultivue
Ultivue
Series D$107.3M562015Cambridge, MA, US
Co-Founder

Leadership at Ultivue

Fenel EloiFenel EloiBoard Member
Ralf JungmannRalf JungmannCo-Founder
Keith CrandellKeith CrandellBoard Member
Peng YinPeng YinCo-Founder
Adam WieschhausAdam WieschhausBoard Member
Rob CarsonRob CarsonCEO

Similar to Ultivue

Altos LabsAltos LabsRedwood City, CA, USCell Therapiesest. 2021Altos LabsRedwood City, CA, US · est. 2021

Altos Labs, Inc.: An American biotech firm pioneering life extension therapies via specialized cell therapies since 2022.

Series A · $3B500
Zinnia TechnologiesZinnia TechnologiesChicago, IL, USCare Toolsest. 2019Zinnia TechnologiesChicago, IL, US · est. 2019

Zinnia Technologies: A leading care tool provider, offering rewarding careers and a balanced work-life culture.

Pre-Seed · $120k6
ClearLight BiotechnologiesClearLight BiotechnologiesSunnyvale, CA, US3D Imaging, Tissue Analysisest. 2015ClearLight BiotechnologiesSunnyvale, CA, US · est. 2015

ClearLight Biotechnologies: Innovating non-destructive 3D tissue analysis for clinical research.

Seed · $12.3M11
Upstream BioUpstream BioWaltham, MA, USAntibody Therapyest. 2021Upstream BioWaltham, MA, US · est. 2021

Upstream Bio: Clinical-stage developer of monoclonal antibody therapy for severe asthma.

Series B · $408M17
LISNR
LISNR
Series C$30.8M332012Cincinnati, OH, US
Board Member· Board

Leadership at LISNR

Blair GarrouBlair GarrouBoard Member
Dave MatterDave MatterBoard Member
Chris OstoichChris OstoichCo-Founder
Donald BoedingDonald BoedingBoard Member
Josh GlickJosh GlickCo-Founder
Sunil KurkureSunil KurkureBoard Member

Similar to LISNR

CUE AudioCUE AudioDenver, CO, USAudio Softwareest. 2017CUE AudioDenver, CO, US · est. 2017

CUE: A data-over-audio tech company using ultrasonic sound for seamless, internet-free connections.

Angel · $50k37
TrillbitTrillbitBoston, MA, USAuthentication, Securityest. 2017TrillbitBoston, MA, US · est. 2017

Trillbit, a Boston-based startup, leverages ubiquitous audio tech to create an 'internet of sound' for seamless device authentication.

Seed · $2.4M25
Listen TechnologiesListen TechnologiesBluffdale, UT, USAssistive Listeningest. 1998Listen TechnologiesBluffdale, UT, US · est. 1998

Listen Technologies: Enhancing experiences with superior assistive listening systems.

Public · $7.4M69
SoLo Funds
SoLo Funds
Series B$13M1752018Los Angeles, CA, US
Co-Founder

Leadership at SoLo Funds

Jarrel CarterJarrel CarterCo-Founder
Taylor BrunoTaylor BrunoCo-Founder
Travis HolowayTravis HolowayCo-Founder
Rodney WilliamsRodney WilliamsCo-Founder
Faith SedlinFaith SedlinBoard Member
Sherlock Biosciences
Sherlock Biosciences

Allston-Brighton, MA, US

Co-Founder

David Walt's Co-Investors

Hugh EvansHugh EvansCo-invested · Stoicheia SeedLouis SimpsonLouis SimpsonCo-invested · Stoicheia SeedCraig MundieCraig MundieCo-invested · Stoicheia SeedWally LoewenbaumWally LoewenbaumCo-invested · Stoicheia SeedJoe AllisonJoe AllisonCo-invested · Stoicheia SeedJoe AllisonJoe AllisonCo-invested · Stoicheia SeedAristides PatrinosAristides PatrinosCo-invested · Lunadna Series UnknownScott KahnScott KahnCo-invested · Lunadna Seed

David Walt's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to David Walt

Charles GersbachCharles GersbachCo-Founder · Tune TherapeuticsStephen JacobsenStephen JacobsenFounder · Sarcos Technology & RoboticsVivek KumarVivek KumarFounder & CEO · SaphtxWarren M GrillWarren M GrillBoard Member · NDI MedicalGerald LoebGerald LoebFounder · SynTouchCharleson BellCharleson BellCo-Founder · Stroll